C.J.A. Punt

Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983

E. Tanis, Bernard Nordlinger, Murielle Mauer et al. · European Journal of Cancer · 2014 · 222 citations

Medicine, Oncology, Surgery +16

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy

Martin J. van den Bent, J. Kros, J.J. Heimans et al. · Neurology · 1998 · 203 citations

Medicine, Oncology, Pharmacology +16

Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study

Thierry André, Kai Keen Shiu, Tae Won Kim et al. · Annals of Oncology · 2024 · 105 citations · Full text

Medicine, Oncology, Chemotherapy +16

Prognostic value of <i>BRAF</i> and <i>KRAS</i> mutation status in stage II and III microsatellite instable colon cancers

Erienne M.V. de Cuba, Daniëlle A.M. Heideman, Nicole C.T. van Grieken et al. · International Journal of Cancer · 2015 · 59 citations · Full text

Medicine, Molecular Genetics, Oncology +15

Radiological heterogeneity in response to chemotherapy is associated with poor survival in patients with colorectal liver metastases

Charlotte S. van Kessel, Mariam Samim, Miriam Koopman et al. · European Journal of Cancer · 2013 · 48 citations

Medicine, Oncology, Radiology +16